- Home
- FUSE vs CVM Comparison
FUSE vs CVM Comparison
Compare FUSE & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSE
- CVM
- Stock Information
- Founded
- FUSE 2013
- CVM 1983
- Country
- FUSE United States
- CVM United States
- Employees
- FUSE N/A
- CVM N/A
- Industry
- FUSE EDP Services
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FUSE Technology
- CVM Health Care
- Exchange
- FUSE Nasdaq
- CVM Nasdaq
- Market Cap
- FUSE 48.5M
- CVM 53.1M
- IPO Year
- FUSE N/A
- CVM 1987
- Fundamental
- Price
- FUSE $1.82
- CVM $6.71
- Analyst Decision
- FUSE
- CVM
- Analyst Count
- FUSE 0
- CVM 0
- Target Price
- FUSE N/A
- CVM N/A
- AVG Volume (30 Days)
- FUSE 433.1K
- CVM 91.8K
- Earning Date
- FUSE 01-01-0001
- CVM 08-14-2025
- Dividend Yield
- FUSE N/A
- CVM N/A
- EPS Growth
- FUSE N/A
- CVM N/A
- EPS
- FUSE N/A
- CVM N/A
- Revenue
- FUSE $8,847,000.00
- CVM N/A
- Revenue This Year
- FUSE N/A
- CVM N/A
- Revenue Next Year
- FUSE N/A
- CVM N/A
- P/E Ratio
- FUSE N/A
- CVM N/A
- Revenue Growth
- FUSE 28.65
- CVM N/A
- 52 Week Low
- FUSE $1.65
- CVM $1.98
- 52 Week High
- FUSE $4.25
- CVM $32.70
- Technical
- Relative Strength Index (RSI)
- FUSE N/A
- CVM 35.37
- Support Level
- FUSE N/A
- CVM $6.50
- Resistance Level
- FUSE N/A
- CVM $7.36
- Average True Range (ATR)
- FUSE 0.00
- CVM 0.63
- MACD
- FUSE 0.00
- CVM -0.06
- Stochastic Oscillator
- FUSE 0.00
- CVM 18.32
About FUSE Fusemachines Inc. Common stock
Fusemachines Inc is a provider of enterprise AI products and solutions. The company provides good quality AI education in underserved communities and helping organizations achieve their full potential with AI. The products of the company include AI Studio, Answer Gen, GenAI Engines, and others.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.